Chinese Team Devises Dual-Action Molecule to Redirect Immune Memory Against Tumors Beijing, 8 Jan 2026 (ONA) --- Chinese scientists have developed a novel synthetic molecule that acts as an "intratumoral vaccine," designed to overcome a key limitation of current immunotherapy by redirecting the body’s pre-existing immune memory to attack cancer cells. Researchers from Shenzhen Bay Laboratory and Peking University detailed the innovation in a study published online in the journal “Nature” today. While immune checkpoint blockade therapy has revolutionized cancer ...